State of Wisconsin Investment Board’s Clearside Biomedical CLSD Stock Holding History

State of Wisconsin Investment Board’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,507	Closed	-$52K	–	1545
2019 Q1	$52K	Buy	2,507 +574	+30%	+$11.4K	﹤0.01%	1531
2018 Q4	$31K	Buy	1,933 +933	+93%	+$43.8K	﹤0.01%	1536
2018 Q3	$92K	Hold	1,000	–	–	﹤0.01%	1526
2018 Q2	$160K	Hold	1,000	–	–	﹤0.01%	1438
2018 Q1	$161K	Hold	1,000	–	–	﹤0.01%	1409
2017 Q4	$105K	Hold	1,000	–	–	﹤0.01%	1421
2017 Q3	$131K	Hold	1,000	–	–	﹤0.01%	1426
2017 Q2	$137K	Buy	+1,000	New	+$120K	﹤0.01%	1424

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

State of Wisconsin Investment Board's CLSD Position: Q2 2019 in Review

State of Wisconsin Investment Board sold out of Clearside Biomedical (CLSD) in Q2 2019, closing a stake of 2,507 shares — an estimated $52K sold.

State of Wisconsin Investment Board first reported a position in CLSD in Q2 2017 and held it in 8 quarters. The position peaked at $161K in Q1 2018. 50 funds tracked by Wall St. Rank hold CLSD as of Q2 2019.

State of Wisconsin Investment Board reported no remaining Clearside Biomedical position as of Q2 2019 after selling out during the quarter.
State of Wisconsin Investment Board sold 2,507 Clearside Biomedical shares in Q2 2019, an estimated $52K.
State of Wisconsin Investment Board first reported a position in Clearside Biomedical in Q2 2017 and held it in 8 quarters.
State of Wisconsin Investment Board's Clearside Biomedical position peaked at $161K in Q1 2018.
50 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2019.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2019, filed 14 Aug 2019.